	Effect of Androgen Deprivation Therapy on Cardiovascular Function in Patients with Advanced Prostate Carcinoma: a Prospective Cohort Study. Indian J Surg Oncol Arulraj K, Kumar L, Nayak B, Singh P, Yadav S, Seth A. PMID: 41415738 [PubMed]
	Comparison of Biparametric MRI and Multiparametric MRI Using Split Dynamic MRI in Prostate Cancer Diagnosis. J Korean Soc Radiol Kim BK, Yang DM, Jahng GH, Kim HC, Kim SW, Lee HL, Min GE, Won KY, Kwon HJ, Bjørnerud A. PMID: 41415640 [PubMed]
	PI-RR: A Reporting System for Local Prostate Cancer Recurrence Evaluation After Radiation Therapy or Radical Prostatectomy. J Korean Soc Radiol Seo JY. PMID: 41415633 [PubMed]
	Standardizing Prostate MRI Reporting in Active Surveillance for Prostate Cancer: The PRECISE Framework. J Korean Soc Radiol Kim MJ, Kang KA, Kim CK. PMID: 41415631 [PubMed]
	Darolutamide-based triple therapy combined with PSMA imaging guided focal treatment in patients with prostate cancer: a multicenter retrospective study. Front Pharmacol Zhong D, Zhang R, Wu J, Guo Z, Zhang Y, Zhou Q, Zou Z, Lin D, Lu Z, Wang J, Wu J, Ye L, Wei Y. PMID: 41415573 [PubMed]
	Comprehensive bioinformatics and in vitro studies reveal the carcinogenic role and molecular basis of endocrine disruptors in prostate cancer. Front Cell Dev Biol Yu F, Che B, Li W. PMID: 41415207 [PubMed]
	Consensus-based Recommendations on the Management of Immunosuppression After Squamous Cell Carcinoma Diagnosis in Kidney Transplant Recipients: An International Delphi Consensus Statement. Transplant Direct Whitley MJ, Wang JX, Chapman J, de Vries APJ, Chandran S, Glennon CM, Madariaga HM, Carroll RP, Booth J, Concepcion B, Couzi L, De Serres SA, Doyle A, Forbes S, Gleadle JM, Griffin S, Gunaratnam L, Gupta G, Ho J, Hughes P, Isbel N, Jegatheesan DK, Jones G, Kuypers D, Lee B, Lim W, Mason P, Meneghini M, Owoyemi I, Rao S, Salama A, Sharif A, Thaunat O, Thuraisingham R, Wyburn K, Yabu JM, Jambusaria-Pahlajani A, Bottomley MJ, Arron ST. PMID: 41415033 [PubMed]
	Robot-Assisted Partial Nephrectomy for Upper Versus Lower Pole Renal Tumors: Perioperative Outcomes and Technical Insights Incorporating the da Vinci and Hinotori Systems. Asian J Endosc Surg Motoyama D, Watanabe K, Matsushita Y, Watanabe H, Tamura K, Miyake H, Inamoto T. PMID: 41414980 [PubMed - indexed for MEDLINE]
	Beam commissioning of a new compact scanned proton therapy system with four different dose calculation algorithms. J Appl Clin Med Phys Tanokura R, Horita M, Matsumoto M, Miyahara A, Furukawa S, Ido Y, Matsumoto A, Ogawa S, Makino W, Matsui Y, Tominaga Y, Kato T, Fuwa N. PMID: 41414875 [PubMed - indexed for MEDLINE]
	Clinical validation of AI-assisted contouring in prostate radiation therapy treatment planning: Highlighting automation bias and the need for standardized quality assurance. J Appl Clin Med Phys Arjmandi N, Sebzari AR, Molaei F, Rezaei S, Rezaie-Yazdi M, Rezaie-Yazdi M. PMID: 41414851 [PubMed - indexed for MEDLINE]
	Carboxylic Acid-Functionalized Î²-Ketoenamine Linked Porous Organic Polymer Based Fluorescent Immunoassay for Prostate Cancer Detection. Luminescence Prasad ST, Joy AM, Ramakrishnan K. PMID: 41413939 [PubMed - indexed for MEDLINE]
	[(18)F]-Fluciclovine or [(68)Ga]-PSMA-11 Molecular Imaging To Guide Dose Escalation of Salvage Radiotherapy After Radical Prostatectomy for Prostate Cancer: The EMPIRE-2 Trial. Eur Urol Jani AB, Dhere VR, Goyal S, Schreibmann E, Patel PR, Hershatter B, Shelton JW, Hanasoge S, Sebastian NT, Patel SA, Halkar R, Cooper S, Fielder B, Abiodun-Ojo OA, Lawal I, Mushtaq A, Master VA, Joshi SS, Kucuk O, Bilen MA, Schuster DM. PMID: 41412908 [PubMed - as supplied by publisher]
	Primary Noncontrast Magnetic Resonance Imaging for Prostate Cancer Screening: A Randomized Clinical Trial (PROSA). Eur Urol Messina E, Borrelli A, Sciarra A, Laschena L, Antonini D, Shaholli D, Magliocca FM, Novelli S, Santini D, La Torre G, Panebianco V. PMID: 41412906 [PubMed - as supplied by publisher]
	Intraoperative Skills for Transurethral Resection of Bladder Tumor: Objective Assessment and Construct Validity of the ENTRY Metrics. Eur Urol Focus Diana P, Paciotti M, Frego N, Gallioli A, Di Bello F, Arena P, Uleri A, Sordelli F, Garofano G, Dieguez L, Sedigh O, Gontero P, Gallagher A, Mottrie A, Palou J, Breda A, Buffi NM. PMID: 41412888 [PubMed - as supplied by publisher]
	Docetaxel with Androgen Deprivation and Radiotherapy in High-risk Localized Prostate Cancer: An ICECaP Individual Patient Data Meta-analysis. Eur Urol Oncol Ravi P, Kwak L, Xie W, D'Amico A, Dignam J, Fizazi K, James N, Teuff GL, Nguyen PL, Sandler H, Sartor O, Sydes MR, Sweeney CJ. PMID: 41412841 [PubMed - as supplied by publisher]
	Clinical Evaluation of a Novel Deintensified Surveillance Protocol for Low-risk Non-muscle-invasive Bladder Cancer: A Prospective Study in 250 Patients. Eur Urol Oncol Shah CP, Gray J, Lord-McKenzie T, Mariappan P. PMID: 41412840 [PubMed - as supplied by publisher]
	Types of biomimetic materials and their emerging clinical applications in the field for prostate cancer. Int J Biol Macromol Guo C, Gui J, Chen A, Li S, Gu C, Deng Y, Wang L, Wang R, Ni J, Wang J, Wang J, Yang D, Qin Y, Zhu L, Wu S, Mi Y. PMID: 41412245 [PubMed - as supplied by publisher]
	[ISUP 1 Prostate Carcinoma Controversy: Is the Term Carcinoma Justified - Clinical or Anatomical Definition?]. Aktuelle Urol Kristiansen G, Bernhardt M, Krausewitz P, Ritter M. PMID: 41412197 [PubMed - as supplied by publisher]
	Phenotypic stratification predicts the pace, but not the outcome, of continence recovery after radical prostatectomy. PLoS One Terek-Derszniak M, G, Biskup M, Skowronek T, Nowak M, Falana J, Jaskulski J, Obarzanowski M, Gozdz S, Macek P. PMID: 41411254 [PubMed - indexed for MEDLINE]
	Construction of a nomogram model for clinically significant prostate cancer based on biparametric magnetic resonance imaging. Int Urol Nephrol Wang P, Ji G, Liu Q, Yang Y, Wang Y, Sica G, Liu J, Xiao S, Liu F, Zhang Q. PMID: 41410894 [PubMed - as supplied by publisher]

Articles 1 - 20 / 174665

Page 1 of 8734



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy